These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17125262)

  • 1. Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1.
    Tavares FX; Al-Barazanji KA; Bigham EC; Bishop MJ; Britt CS; Carlton DL; Feldman PL; Goetz AS; Grizzle MK; Guo YC; Handlon AL; Hertzog DL; Ignar DM; Lang DG; Ott RJ; Peat AJ; Zhou HQ
    J Med Chem; 2006 Nov; 49(24):7095-107. PubMed ID: 17125262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonist.
    Tavares FX; Al-Barazanji KA; Bishop MJ; Britt CS; Carlton DL; Cooper JP; Feldman PL; Garrido DM; Goetz AS; Grizzle MK; Hertzog DL; Ignar DM; Lang DG; McIntyre MS; Ott RJ; Peat AJ; Zhou HQ
    J Med Chem; 2006 Nov; 49(24):7108-18. PubMed ID: 17125263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanin concentrating hormone receptor 1 (MCHR1) antagonists-Still a viable approach for obesity treatment?
    Högberg T; Frimurer TM; Sasmal PK
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6039-47. PubMed ID: 22954736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel diarylketoxime derivatives as selective and orally active melanin-concentrating hormone 1 receptor antagonists.
    Suzuki T; Kameda M; Ando M; Miyazoe H; Sekino E; Ito S; Masutani K; Kamijo K; Takezawa A; Moriya M; Ito M; Ito J; Nakase K; Matsushita H; Ishihara A; Takenaga N; Tokita S; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5339-45. PubMed ID: 19683441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas.
    McBriar MD; Guzik H; Shapiro S; Paruchova J; Xu R; Palani A; Clader JW; Cox K; Greenlee WJ; Hawes BE; Kowalski TJ; O'neill K; Spar BD; Weig B; Weston DJ; Farley C; Cook J
    J Med Chem; 2006 Apr; 49(7):2294-310. PubMed ID: 16570926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel phenethylpyridone derivatives as potent melanin-concentrating hormone 1 receptor antagonists.
    Ando M; Sekino E; Haga Y; Moriya M; Ito M; Ito J; Iwaasa H; Ishihara A; Kanatani A; Ohtake N
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5186-90. PubMed ID: 19632840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists.
    Sasmal PK; Sasmal S; Rao PT; Venkatesham B; Roshaiah M; Abbineni C; Khanna I; Jadhav VP; Suresh J; Talwar R; Muzeeb S; Receveur JM; Frimurer TM; Rist Ø; Elster L; Högberg T
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5443-8. PubMed ID: 20724156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New amide derivatives as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.
    Cirauqui N; Ceras J; Galiano S; Pérez-Silanes S; Juanenea L; Rivera G; Aldana I; Monge A
    Arzneimittelforschung; 2008; 58(11):585-91. PubMed ID: 19137910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constrained 7-fluorocarboxychromone-4-aminopiperidine based Melanin-concentrating hormone receptor 1 antagonists: the effects of chirality on substituted indan-1-ylamines.
    Souers AJ; Iyengar RR; Judd AS; Beno DW; Gao J; Zhao G; Brune ME; Napier JJ; Mulhern MM; Lynch JK; Freeman JC; Wodka D; Chen CJ; Falls HD; Brodjian S; Dayton BD; Diaz GJ; Bush EN; Shapiro R; Droz BA; Knourek-Segel V; Hernandez LE; Marsh KC; Reilly RM; Sham HL; Collins CA; Kym PR
    Bioorg Med Chem Lett; 2007 Feb; 17(4):884-9. PubMed ID: 17188866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanin-Concentrating Hormone Receptor 1 Antagonists Lacking an Aliphatic Amine: Synthesis and Structure-Activity Relationships of Novel 1-(Imidazo[1,2-a]pyridin-6-yl)pyridin-2(1H)-one Derivatives.
    Igawa H; Takahashi M; Kakegawa K; Kina A; Ikoma M; Aida J; Yasuma T; Kawata Y; Ashina S; Yamamoto S; Kundu M; Khamrai U; Hirabayashi H; Nakayama M; Nagisa Y; Kasai S; Maekawa T
    J Med Chem; 2016 Feb; 59(3):1116-39. PubMed ID: 26736071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity.
    Souers AJ; Gao J; Brune M; Bush E; Wodka D; Vasudevan A; Judd AS; Mulhern M; Brodjian S; Dayton B; Shapiro R; Hernandez LE; Marsh KC; Sham HL; Collins CA; Kym PR
    J Med Chem; 2005 Mar; 48(5):1318-21. PubMed ID: 15743174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonists.
    Kym PR; Iyengar R; Souers AJ; Lynch JK; Judd AS; Gao J; Freeman J; Mulhern M; Zhao G; Vasudevan A; Wodka D; Blackburn C; Brown J; Che JL; Cullis C; Lai SJ; LaMarche MJ; Marsilje T; Roses J; Sells T; Geddes B; Govek E; Patane M; Fry D; Dayton BD; Brodjian S; Falls D; Brune M; Bush E; Shapiro R; Knourek-Segel V; Fey T; McDowell C; Reinhart GA; Preusser LC; Marsh K; Hernandez L; Sham HL; Collins CA
    J Med Chem; 2005 Sep; 48(19):5888-91. PubMed ID: 16161992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Building a MCHR1 homology model provides insight into the receptor-antagonist contacts that are important for the development of new anti-obesity agents.
    Cirauqui N; Schrey AK; Galiano S; Ceras J; Pérez-Silanes S; Aldana I; Monge A; Kühne R
    Bioorg Med Chem; 2010 Nov; 18(21):7365-79. PubMed ID: 20932767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of imidazo[1,2-a]pyridines as potent MCH1R antagonists.
    Kishino H; Moriya M; Sakuraba S; Sakamoto T; Takahashi H; Suzuki T; Moriya R; Ito M; Iwaasa H; Takenaga N; Ishihara A; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4589-93. PubMed ID: 19615899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanin-concentrating hormone receptor 1 antagonists. Synthesis and structure-activity relationships of novel 3-(aminomethyl)quinolines.
    Kamata M; Yamashita T; Imaeda T; Tanaka T; Masada S; Kamaura M; Kasai S; Hara R; Sasaki S; Takekawa S; Asami A; Kaisho T; Suzuki N; Ashina S; Ogino H; Nakano Y; Nagisa Y; Kato K; Kato K; Ishihara Y
    J Med Chem; 2012 Mar; 55(5):2353-66. PubMed ID: 22309223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a nonbasic melanin hormone receptor 1 antagonist as an antiobesity clinical candidate.
    Washburn WN; Manfredi M; Devasthale P; Zhao G; Ahmad S; Hernandez A; Robl JA; Wang W; Mignone J; Wang Z; Ngu K; Pelleymounter MA; Longhi D; Zhao R; Wang B; Huang N; Flynn N; Azzara AV; Barrish JC; Rohrbach K; Devenny JJ; Rooney S; Thomas M; Glick S; Godonis HE; Harvey SJ; Cullen MJ; Zhang H; Caporuscio C; Stetsko P; Grubb M; Maxwell BD; Yang H; Apedo A; Gemzik B; Janovitz EB; Huang C; Zhang L; Freeden C; Murphy BJ
    J Med Chem; 2014 Sep; 57(18):7509-22. PubMed ID: 25165888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibition.
    Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4268-73. PubMed ID: 19500979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics.
    McBriar MD; Guzik H; Xu R; Paruchova J; Li S; Palani A; Clader JW; Greenlee WJ; Hawes BE; Kowalski TJ; O'Neill K; Spar B; Weig B
    J Med Chem; 2005 Apr; 48(7):2274-7. PubMed ID: 15801820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amine-free melanin-concentrating hormone receptor 1 antagonists: Novel 1-(1H-benzimidazol-6-yl)pyridin-2(1H)-one derivatives and design to avoid CYP3A4 time-dependent inhibition.
    Igawa H; Takahashi M; Shirasaki M; Kakegawa K; Kina A; Ikoma M; Aida J; Yasuma T; Okuda S; Kawata Y; Noguchi T; Yamamoto S; Fujioka Y; Kundu M; Khamrai U; Nakayama M; Nagisa Y; Kasai S; Maekawa T
    Bioorg Med Chem; 2016 Jun; 24(11):2486-2503. PubMed ID: 27112449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel MCH1 receptor antagonists: a patent review.
    Johansson A; Löfberg C
    Expert Opin Ther Pat; 2015 Feb; 25(2):193-207. PubMed ID: 25522065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.